Comparison results
Results: Differences Similar | ✘Bacteremia | ✘Jessner-Kanof lymphocytic infiltration | |||||||
Related research | Analogs | Analogs | |||||||
| |||||||||
Distinctive symptoms | |||||||||
Register, to see more distinctive signs of diseases and studies | 84% | — | |||||||
Register, to see more distinctive signs of diseases and studies | — | 100% | |||||||
folliculitis | 82% | — | |||||||
mchc reduced | — | 90% | |||||||
bad breath unpleasant | 78% | — | |||||||
tick bite | — | 33% | |||||||
suppuration of the skin | 100% | 29% | |||||||
pink spots on the skin | — | 32% | |||||||
abscess | 66% | — | |||||||
hormonal ointments | — | 31% | |||||||
bilateral pneumonia | 66% | — | |||||||
pink spots | — | 31% | |||||||
wounds | 58% | — | |||||||
skin mite | — | 30% | |||||||
hyperthyroidism | 56% | — | |||||||
rashes on the palms | — | 27% | |||||||
thyrotoxicosis | 48% | — | |||||||
rash on the wrists | — | 26% | |||||||
diffuse toxic goiter | 47% | — | |||||||
growths on the skin | — | 26% | |||||||
enlargement of the thyroid gland | 43% | — | |||||||
lymphocytosis | — | 26% | |||||||
necrosis | 34% | — | |||||||
peeling | — | 24% | |||||||
bacteremia | 32% | — | |||||||
oncology | — | 24% | |||||||
sepsis | 19% | — | |||||||
purulent rashes on the skin | — | 24% | |||||||
foreign body sensation | 18% | — | |||||||
skin problems | — | 24% | |||||||
cardiac disorder | 17% | — | |||||||
dermatosis | — | 24% | |||||||
osteomyelitis | 16% | — | |||||||
alternating symptoms | — | 23% | |||||||
blood diseases | 16% | — | |||||||
inflammatory infiltrate | — | 23% | |||||||
meningitis | 16% | — | |||||||
rash pustules | — | 23% | |||||||
bacterial pneumonia | 16% | — | |||||||
painful appearance | — | 22% | |||||||
endocarditis | 15% | — | |||||||
blue skin | — | 22% | |||||||
inflammation of the brain | 15% | — | |||||||
dermatitis | — | 21% | |||||||
shock states of various genesis | 15% | — | |||||||
vascular tumor | — | 20% | |||||||
intestinal mucosa | 15% | — | |||||||
papules | — | 20% | |||||||
weakening of immunity | 15% | — | |||||||
consequences of infection | — | 18% | |||||||
pneumonia | 14% | — | |||||||
diseases of the gastrointestinal tract | 12% | 25% | |||||||
immunodeficiency | 13% | — | |||||||
consequences of taking medications | 11% | 23% | |||||||
damage to the nervous system | 12% | — | |||||||
inflammatory bowel diseases | 14% | 21% | |||||||
consequences of operation | 12% | — | |||||||
inflammation of the stomach | 15% | 22% | |||||||
intestinal infection | 16% | 23% | |||||||
impaired function of the large intestine | 16% | 23% | |||||||
functional disorders of the stomach | 13% | 19% | |||||||
patient's condition | 11% | 16% | |||||||
surgical infections | 18% | 19% | |||||||
disease operation | 16% | 17% |
Instructions
Video
|